FourThought Financial Partners LLC Has $322,000 Holdings in Stryker Co. (NYSE:SYK)

FourThought Financial Partners LLC increased its holdings in shares of Stryker Co. (NYSE:SYK) by 3.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 1,076 shares of the medical technology company’s stock after purchasing an additional 34 shares during the period. FourThought Financial Partners LLC’s holdings in Stryker were worth $322,000 as of its most recent filing with the SEC.

Other institutional investors have also added to or reduced their stakes in the company. Forte Capital LLC ADV boosted its stake in shares of Stryker by 2.2% in the 4th quarter. Forte Capital LLC ADV now owns 5,420 shares of the medical technology company’s stock worth $1,623,000 after buying an additional 115 shares during the last quarter. Charles Carroll Financial Partners LLC lifted its stake in Stryker by 20.2% in the 4th quarter. Charles Carroll Financial Partners LLC now owns 4,530 shares of the medical technology company’s stock valued at $1,356,000 after buying an additional 760 shares in the last quarter. First National Trust Co raised its position in shares of Stryker by 169.5% during the 4th quarter. First National Trust Co now owns 9,380 shares of the medical technology company’s stock valued at $2,809,000 after buying an additional 5,900 shares during the period. Royal Fund Management LLC grew its stake in shares of Stryker by 4.3% during the fourth quarter. Royal Fund Management LLC now owns 7,952 shares of the medical technology company’s stock worth $2,381,000 after purchasing an additional 327 shares in the last quarter. Finally, AJOVista LLC purchased a new stake in shares of Stryker in the fourth quarter valued at about $129,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Canaccord Genuity Group raised shares of Stryker from a “hold” rating to a “buy” rating and raised their price objective for the stock from $315.00 to $360.00 in a report on Wednesday, January 31st. Truist Financial increased their price target on shares of Stryker from $330.00 to $345.00 and gave the company a “hold” rating in a research report on Wednesday, January 31st. Citigroup upped their price objective on shares of Stryker from $362.00 to $406.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Stifel Nicolaus upped their price objective on Stryker from $350.00 to $375.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Finally, TD Cowen lifted their price objective on Stryker from $365.00 to $400.00 and gave the stock a “buy” rating in a report on Thursday, April 11th. Four analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, Stryker has an average rating of “Moderate Buy” and a consensus target price of $365.94.

Insider Buying and Selling at Stryker

In other news, CAO William E. Berry, Jr. sold 7,690 shares of the company’s stock in a transaction that occurred on Thursday, March 7th. The stock was sold at an average price of $358.48, for a total transaction of $2,756,711.20. Following the sale, the chief accounting officer now directly owns 3,675 shares of the company’s stock, valued at approximately $1,317,414. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 5.50% of the company’s stock.

Stryker Stock Performance

Stryker stock traded down $3.28 during midday trading on Monday, hitting $325.17. The company’s stock had a trading volume of 421,449 shares, compared to its average volume of 1,317,238. Stryker Co. has a 1-year low of $249.98 and a 1-year high of $361.41. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.71 and a quick ratio of 0.99. The company has a 50-day moving average price of $346.99 and a two-hundred day moving average price of $317.97. The company has a market cap of $123.87 billion, a price-to-earnings ratio of 37.49, a PEG ratio of 2.56 and a beta of 0.91.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Tuesday, April 30th. The medical technology company reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.36 by $0.14. Stryker had a net margin of 16.03% and a return on equity of 23.05%. The company had revenue of $5.24 billion for the quarter, compared to analyst estimates of $5.10 billion. During the same period in the previous year, the firm posted $2.14 EPS. The firm’s revenue was up 9.7% on a year-over-year basis. As a group, sell-side analysts predict that Stryker Co. will post 11.94 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 30th. Shareholders of record on Friday, March 29th were given a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date of this dividend was Wednesday, March 27th. Stryker’s payout ratio is currently 36.53%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.